337. Homocystinuria Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 16 / Drugs : 19 - (DrugBank : 7) / Drug target genes : 2 - Drug target pathways : 23
Homocystinuria and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 337 | Homocystinuria | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 2.000 |
| 6 | Parkinson disease | 2.000 |
| 21 | Mitochondrial disease | 2.000 |
| 299 | Cystic fibrosis | 2.000 |
| 231 | Alpha-1-antitrypsin deficiency | 2.000 |
| 34 | Neurofibromatosis | 2.000 |
| 35 | Pemphigus | 2.000 |
| 46 | Malignant rheumatoid arthritis | 2.000 |
| 49 | Systemic lupus erythematosus | 2.000 |
| 51 | Scleroderma | 2.000 |
| 65 | Primary immunodeficiency | 2.000 |
| 86 | Pulmonary arterial hypertension | 2.000 |
| 96 | Crohn disease | 2.000 |
| 158 | Tuberous sclerosis | 2.000 |
| 222 | Primary nephrotic syndrome | 2.000 |
| 256 | Muscle glycogenosis | 2.000 |
| 271 | Ankylosing spondylitis | 2.000 |
| 5 | Progressive supranuclear palsy | 2.000 |
| 113 | Muscular dystrophy | 2.000 |
| 78 | Hypopituitarism | 2.000 |
| 107 | Juvenile idiopathic arthritis | 2.000 |
| 298 | Hereditary pancreatitis | 2.000 |
| 97 | Ulcerative colitis | 2.000 |
| 300 | IgG4-related disease | 2.000 |
| 206 | Fragile X syndrome | 2.000 |
| 225 | Congenital nephrogenic diabetes insipidus | 2.000 |
| 58 | Hypertrophic cardiomyopathy | 2.000 |
| 226 | Interstitial cystitis with Hunners ulcer | 2.000 |
| 11 | Myasthenia gravis | 2.000 |
| 22 | Moyamoya disease | 2.000 |
| 70 | Spinal stenosis | 2.000 |
| 210 | Single Ventricle | 2.000 |
| 3 | Spinal muscular atrophy | 2.000 |
| 251 | Urea cycle disorder | 2.000 |